(A) Immediately after reperfusion, there was no difference between the two groups (p=0.46). (B) At 48 hours, glibenclamide improved the neurological score (* p<0.05). Both indirect (C) and direct (D) stroke volume were significantly reduced by glibenclamide (** p<0.01). The swelling volume of ischemic core (E) and the ipsilateral, surrounding TTC positive brain tissue (F) were significantly reduced by glibenclamide (* p<0.05, ** p<0.01, respectively). (G) Concomitantly, estimated total brain water content was reduced by glibenclamide (* p<0.05).